SURAKSHA DIAGNOSTIC
Back to Cashflow Statement
|
SURAKSHA DIAGNOSTIC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-24 Cr | ₹-25 Cr | ₹-24 Cr | ₹1.09 Cr | ₹3.21 Cr |
What is the latest Cash Flow from Financing Activities ratio of SURAKSHA DIAGNOSTIC ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-24 Cr |
| Mar2024 | ₹-25 Cr |
| Mar2023 | ₹-24 Cr |
| Mar2022 | ₹1.09 Cr |
| Mar2021 | ₹3.21 Cr |
How is Cash Flow from Financing Activities of SURAKSHA DIAGNOSTIC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-24 Cr | Negative | |
| Mar2024 | ₹-25 Cr | Negative | |
| Mar2023 | ₹-24 Cr | Negative | |
| Mar2022 | ₹1.09 Cr | -66.15 | |
| Mar2021 | ₹3.21 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SURAKSHA DIAGNOSTIC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SURAKSHA DIAGNOSTIC | ₹1,326.5 Cr | -4.2% | -11% | -2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,144.0 Cr | -0.1% | 9.3% | 25% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹101,484.0 Cr | -3.9% | -0% | 7.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹66,523.1 Cr | -5.8% | 2.5% | 42.1% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,763.1 Cr | -1.7% | 1.4% | 8.6% | Stock Analytics | |
| GLOBAL HEALTH | ₹29,736.3 Cr | -3.4% | -1.6% | -8.5% | Stock Analytics | |
SURAKSHA DIAGNOSTIC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SURAKSHA DIAGNOSTIC | -4.2% |
-11% |
-2% |
| SENSEX | -4.6% |
-7.5% |
6% |
You may also like the below Video Courses